High-Throughput Monoclonal Antibody Peptide Mapping Using 15-s HPLC Gradients Coupled with Cyclic Ion Mobility-Mass
Devin M Makey1, Brandon T Ruotolo1, Robert T Kennedy1,2
1Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Analytical Chemistry
|August 1, 2025
Summary
This study introduces a rapid peptide mapping technique using fast liquid chromatography with cyclic ion mobility-mass spectrometry (LC-cIM-MS) for analyzing monoclonal antibodies (mAbs). The method significantly enhances throughput for critical quality attribute (CQA) analysis, accelerating therapeutic development.
Area of Science:
- Biochemistry and Biophysics
- Analytical Chemistry
- Pharmaceutical Sciences
Background:
- Accurate characterization of critical quality attributes (CQAs) like sequence variants and post-translational modifications (PTMs) is vital for monoclonal antibody (mAb) safety and efficacy.
- Traditional peptide mapping with liquid chromatography-mass spectrometry (LC-MS) offers simultaneous CQA monitoring but lacks the throughput for rapid analysis.
Purpose of the Study:
- To develop a high-throughput peptide mapping workflow for comprehensive mAb analysis.
- To enable rapid and high-resolution characterization of CQAs in mAb therapeutics.
Main Methods:
- Implementation of a multidimensional, high-throughput peptide mapping workflow combining fast liquid chromatography (LC) with cyclic ion mobility-mass spectrometry (cIM-MS).
- Utilized a 15-s LC gradient coupled with single-pass cIM-MS for analyzing tryptic digests of mAbs.
- Employed mobility-aligned collision-induced dissociation for precise localization of PTMs.
Main Results:
- Achieved a peak capacity of 490 and analyzed a 96-well plate in 37 minutes, demonstrating high throughput.
- Obtained 97% sequence coverage with robust reproducibility in retention time, arrival time, and peak intensity.
- Demonstrated a linear dynamic range across nearly two orders of magnitude and successfully tracked PTM kinetics during forced degradation.
Conclusions:
- The fast LC-cIM-MS platform provides a robust and efficient approach for assessing CQAs in high-throughput applications like stability studies and process monitoring.
- This method has the potential to significantly accelerate mAb development and manufacturing by enabling faster analysis.
- Highlights the utility of fast multidimensional separations for complex biological sample analysis.


